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During the genomic era, a large amount of whole genome sequences accumulated, 24	  
which identified many hypothetical proteins of unknown function. Rapidly, functional 25	  
genomics, which is the research domain that assign a function to a given gene product, 26	  
has thus been developed. Functional genomics of intracellular pathogenic bacteria 27	  
exhibit specific peculiarities due to the fastidious growth of most of these intracellular 28	  
micro-organisms, due to the close interaction with the host cell, due to the risk of 29	  
contamination of experiments with host cell proteins and, for some strict intracellular 30	  
bacteria such as Chlamydia, due to the absence of simple genetic system to manipulate 31	  
the bacterial genome. In order to identify virulence factors of intracellular pathogenic 32	  
bacteria, functional genomics often rely on bioinformatic analyses compared to model 33	  
organisms such as E. coli and B. subtilis. The use of heterologous expression is another 34	  
common approach. Given the intracellular lifestyle and the many effectors that are used 35	  
by the intracellular bacteria to corrupt host cell functions, functional genomics is also 36	  
often targeting the identification of new effectors such as those of the T4SS of Brucella 37	  
and Legionella.   38	  
 39	  
  40	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1. Introduction 41	  
In the late 1990’s, the development of automated-DNA sequencing revolutionized 42	  
microbiology through the availability of complete genomes of bacteria. The first bacterial 43	  
genome sequence was reported for the bacterial pathogen Haemophilus influenzae in 44	  
1995 [1]. The availability of a complete genome sequence rapidly appeared to be 45	  
insufficient to understand the complexity of the bacterial world. The genome sequence 46	  
data is not an end by itself but rather the starting point to raise testable functional 47	  
hypotheses. Thus, the transition to the 21st century gave rise to a large increase of 48	  
research in functional genomics, often referred as the post-genomic era (Figure 1). 49	  
Functional genomics consist to assign a function to a protein encoded by a given gene. 50	  
A key feature of functional genomics is the “genome-wide” approach that requires 51	  
adapting the experimental design to large-scale research. Basically, functional 52	  
genomics is based onto two main approaches: the sequence-based and the 53	  
experiment-based function assignment. Sequence-based functional genomics relies 54	  
mainly on similarity of sequence at nucleotide and/or protein levels as well as, the 55	  
overall structure and composition of a genome. This approach provides clues but does 56	  
not establish gene product function and needs experimental verification. On the other 57	  
hand, experience-based functional genomics relies on experiments performed at 58	  
different levels such as DNA (transpositional screen, random mutagenesis), RNA 59	  
(microarrays, RNAseq) and protein (2D gel followed by mass spectrometry, ORFeome, 60	  
heterologous expression,...). Studying the function at the protein level helps 61	  
characterizing directly the molecular actors in the cell and also includes most functional 62	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screens such as protein-protein interactions, subcellular localization as well as, 63	  
secretion/translocation screens.  64	  
Functional genomics was first applied to model organisms such as E. coli and B. subtilis 65	  
and then to pathogenic bacteria in order to gain insight on their virulence factors. 66	  
Functional genomics of intracellular bacteria cannot be directly extrapoled from 67	  
functional genomics data of E. coli because gene content and function largely reflects 68	  
the ecology of a given bacterium and sustained host-pathogen interactions shape the 69	  
bacterial genomes of intracellular bacteria. This review is devoted to functional 70	  
genomics of facultative and obligate intracellular pathogenic bacteria. Obligate 71	  
intracellular pathogenic bacteria only proliferate inside host cells and no defined media 72	  
are yet available that sustain their bacterial growth whereas, facultative intracellular 73	  
bacteria may be grown axenically on synthetic media. Functional genomics of 74	  
intracellular bacteria implies two major challenges: (i) to distinguish the bacterial 75	  
components of interest from the cellular fraction of the host eukaryotic cell, (ii) the low 76	  
number of intracellular bacteria at early time point post-infection (p.i.) (before bacterial 77	  
proliferation) forces the experimenter to deal with low amount of bacterial components. 78	  
Moreover, the absence of simple genetic system for some strict intracellular bacteria, 79	  
such as Chlamydia spp., is another challenge that explains the large variety of 80	  
functional genomics approaches that have been developed by chlamydologists. In 81	  
addition to Chlamydia, this review will also focus on functional genomics applied to 82	  
study two facultative intracellular pathogenic bacteria, Brucella spp. and Legionella spp.. 83	  
and will present the different strategies used to identify the effectors translocated into 84	  
the host cell thanks to their Type IV secretion system (T4SS).  85	  
5	  
	  
  86	  
Functional genomics of Brucella  87	  
Generalities 88	  
Brucella spp. are the ethiological agent of brucellosis, a widespread worldwide zoonosis 89	  
affecting a large range of mammals including humans and responsible of dramatic 90	  
economical losses in endemic countries. Brucella spp. are Gram-negative bacteria 91	  
belonging to alpha-2 subclass of Proteobacteria [2]. The Brucella genus is divided into 92	  
10 species according to their hosts [3, 4]. Brucella spp. are able to infect professional 93	  
and non-professional phagocytes. Once internalized, Brucella resides in a vacuole 94	  
called “Brucella containing vacuole” (BCV), which successively interacts with endocytic 95	  
compartments. Then, Brucella reaches the endoplasmic reticulum (ER) at particular 96	  
sites, the ER exit sites (ERES), where it extensively proliferates [5-7]. 97	  
Brucella genome 98	  
The first complete Brucella genomes were reported in 2002 for B. melitensis strain 16M 99	  
and B. suis strain 1330 [8, 9]. The complete genome of Brucella abortus was published 100	  
in 2005 [10]. Before the availability of complete genome sequence, several groups used 101	  
transposon mutagenesis and signature-tagged transposon mutagenesis in order to 102	  
identify virulence factors [11-15]. These experiments were essentially performed in vitro 103	  
on eukaryotic cells and led to the identification of genes essential for intracellular 104	  
survival. These gene products were involved in various pathways such as amino acid 105	  
and DNA metabolism, LPS biosynthesis and the T4SS, which suggested that Brucella 106	  




ORFeome of Brucella 109	  
In 2004, the first B. melitensis ORFeome was constructed [16]. The B. melitensis 110	  
ORFeome is a library of all protein-encoding open reading frame (ORF) cloned in an 111	  
entry vector compatible with the Gateway cloning technology, easily transferrable in 112	  
expression vector by recombination. The ORFeome is a convenient resource for high-113	  
throughput functional genomics and can be used for various purposes such as protein 114	  
over-expression, mutant construction, interaction mapping... Various screens based on 115	  
the ORFeome availability were performed such as (i) functional screen in yeast for anti-116	  
apoptotic effector candidate, (ii) screen for proteins with a polar localization in B. 117	  
abortus or (iii) yeast-two hybrid between all B. melitensis proteins and human 118	  
phagosomal protein or endoplasmic reticulum exit site associated proteins [17-20].  119	  
Thanks to the presence of the same flanking sequences for each coding sequence, the 120	  
ORFeome is also useful for the construction of a PCR product microarrays for the global 121	  
analysis of gene expression of Brucella in laboratory conditions [21]. 122	  
Trancriptional analysis of Brucella 123	  
Transcriptional analysis by using microarrays was essentially performed to study the 124	  
global regulation of a transcriptional regulator. This was the case of BvrR/S, the two 125	  
component system essential for Brucella virulence [22]. The genes regulated by BvrR/S 126	  
were determined by parallel whole genome microarray analyses of the wild type and the 127	  
bvrR mutant strains grown under the same conditions [23]. A similar approach was used 128	  
for VjbR and BabR, two transcriptional factors belonging to LuxR family responding to 129	  
quorum sensing autoinducer, by combining proteomic study to genome microarray 130	  
analyses [24-27]. The aim of this work was to identify the quorum sensing regulon by 131	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focusing on the most likely targets. The putative targets included those identified by 132	  
combining proteomic and microarray analysis and those by the microarray analysis 133	  
alone confirmed by qRT-PCR or chromatin immunoprecipitation (chIP) [27]. 134	  
Other transcriptomic studies were performed in order to identify differences in global 135	  
gene expression level between bacteria subjected to different stimuli or in different 136	  
stages of axenic growth or intracellular growth. Rosetti and colleagues performed a 137	  
microarray analysis between Brucella melitensis at the late logarithmic phase of growth 138	  
(the most invasive culture) and stationary phase (the least invasive). The majority of up-139	  
regulated genes in late-log growth phase were associated with growth, including DNA 140	  
replication, transcription, translation, intermediate metabolism, energy production and 141	  
conversion, membrane transport, and biogenesis of the cell envelope and outer 142	  
membrane [28].  Another study characterized the transcriptional profile at 4h (non-143	  
proliferative phase) and 12h (proliferative phase) after infection of HeLa cells with B. 144	  
melitensis. As many as 151 and 115 genes were differentially expressed at 4 and 12h 145	  
p.i., compared to the inoculum (a culture at late-log phase of growth). These genes 146	  
mainly involved in growth and metabolism were down-regulated at 4h p.i. and up-147	  
regulated at 12h p.i. [29]. The aim of these two studies was first to identify genes 148	  
encoding proteins (i) involved in invasion by comparing transcriptional profile between 149	  
the most and the least invasive growth phase of B. melitensis cultures and (ii) involved 150	  
in survival and proliferation (by comparing transcriptional profile at 4 and 12h p.i). The 151	  
results presented in these studies reflect a global adaptation. It is therefore difficult to 152	  
identify a single gene or a set of gene involved in the invasion, survival or proliferation.  153	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The recent advance in RNAseq provides a novel approach for transcriptomic studies 154	  
where host and pathogen can be both analyzed in parallel. This technique also allows 155	  
the identification of the transcription start site (TSS), alternative TSS and operon 156	  
organization as well as non-coding RNAs, antisense RNAs, and 5'-/3'-untranslated 157	  
regions. Small regulatory RNAs are involved in post-transcriptional regulation and even 158	  
in modification of protein activity. Hfq protein binds RNA and is usually required for the 159	  
function and/or stability of this family of sRNAs, in Gram-negative bacteria [30]. The 160	  
presence of hfq gene in B. abortus genome suggests that such a sRNA regulation exist. 161	  
Until now, only two sRNAs were identified which are both orthologous to AbcR1 and 2 162	  
of A. tumefaciens [31]. Moreover the small regulatory RNAs of Brucella still remain 163	  
poorly known and RNAseq approach should help to study this domain. 164	  
Proteomics investigations 165	  
The first proteomic study of Brucella was performed on bacterial cells grown on blood 166	  
agar in aerobic condition [32]. A total of 883 proteins spots were detected on 2D gel 167	  
among which 440 proteins were identified by mass spectrometry. These proteins 168	  
represent 187 genes that correspond to 6% of the predicted genes present in the 169	  
genome. Later, various proteomic studies were performed on infected cells or on 170	  
bacteria grown under microaerobic or anaerobic conditions [33-35]. It was reported that 171	  
the basal metabolism is reduced under microaerobic and anaerobic conditions, which is 172	  
expected with low or absence of growth. Under these both conditions, glycolysis and 173	  
denitrification were favored. When oxygen became limiting, basic metabolism processes 174	  
were maintained and various respiratory pathways were observed. This flexibility 175	  
confers to Brucella an advantage to survive in low oxygen environments such as 176	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damaged host tissues [34]. Lamontagne and colleagues showed that Brucella prepare 177	  
for cell division soon after their internalization in mouse macrophages by overproducing 178	  
several proteins involved in division and DNA metabolism, such as PleC and XseA [35]. 179	  
In addition to provide such functional information, proteomic studies can also be useful 180	  
to confirm that proteins were correctly annotated in term of length and that they are 181	  
produced [36].  182	  
Brucella VirB T4SS 183	  
The T4SS of Brucella was discovered in 1999, by a transposon mutagenesis screen for 184	  
mutants attenuated during infection of HeLa cells. The involvement of the T4SS VirB in 185	  
Brucella virulence and its regulation were extensively studied [5, 11, 15, 25, 37-40]. 186	  
Briefly, virB expression is regulated by BvR/S and VjbR regulators [25, 39]. It was also 187	  
reported that VirB T4SS is required to sustain interaction with the ER and generate a 188	  
proliferative organelle, probably through the action of translocated effectors into the host 189	  
cell or the vacuolar membrane [5]. A common strategy to identify effectors relies on 190	  
bioinformatic approaches. One study hypothesized that proteins translocated by VirB 191	  
must be co-regulated with the virB operon by the VjbR regulator [41]. A conserved motif, 192	  
in the virB promoter, required for VjbR activation was determined and then 144 193	  
promoters containing this motif were identified. For interesting candidates, translocation 194	  
into macrophages using TEM-β-lactamase reporter were tested. Thus, two proteins, 195	  
VceA and VceC, were reported as the first T4SS substrates. A second genome-wide 196	  
bioinformatics screen was initiated to identify additional effectors. This screen was 197	  
based on different criteria such as the homology to known effectors and the occurrence 198	  
of eukaryotic-like domain or motif. Using this bioinformatic approach, 84 B. abortus 199	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putative effectors (BPEs) were identified [42]. Translocation of these putative effectors 200	  
was tested using adenylate cyclase reporter and six were translocated into the 201	  
eukaryotic cytoplasm.  202	  
Another strategy to identify effectors, consist to focus on a particular feature of these 203	  
effectors such as their interactions with host proteins, as well as their translocation into 204	  
host cell cytoplasm. In this prospect, a genome-wide yeast-two hybrid between all B. 205	  
melitensis and human phagosomal protein was performed [18]. This approach was 206	  
possible thanks to the availability of both human and B. melitensis ORFeome. A specific 207	  
interaction was identified between the human Rab GTPase Rab2 and a Brucella protein 208	  
called RicA. This interaction was confirmed by GST pull down and RicA was shown to 209	  
be translocated into host cell cytoplasm of macrophages using the TEM-β-lactamase 210	  
reporter. Functional screen in yeast to identify anti-apoptotic effector candidates and 211	  
translocation screen using the Yersinia YopP as a reporter system [17, 44] are 212	  
alternative strategies used to identify T4SS effectors. 213	  
Despite overlapping many different approaches, Brucella effectors still remain poorly 214	  
characterized possibly due to the difficulties to adapt tools and experiments to this 215	  
biosafety level 3 bacterial pathogen. 216	  
 217	  
 218	  
Functional genomics of Legionella  219	  
Generalities 220	  
Legionella pneumophila is a Gram-negative bacterium commonly found in aquatic 221	  
environment where it replicates inside protozoan hosts [45, 46]. L. pneumophila is the 222	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causing agent of a severe pneumonia, called Legionnaires’ disease [47-49]. The 223	  
alveolar macrophages are the primary sites of bacterial proliferation. The L. 224	  
pneumophila virulence seems to rely on its ability to avoid phagosome-lysosome fusion, 225	  
since mutants defective for this particular phenotype are unable to proliferate inside the 226	  
host cell and thus to cause the disease [50, 51]. Once inside the cell, L. pneumophila 227	  
reside in a vacuole called Legionella containing vacuoles (LCV). The LCV rapidly 228	  
acquire the characteristics of an ER-like compartment by recruiting vesicles from the 229	  
early secretory pathway [52]. This is essential for bacterial proliferation and require a 230	  
functional Dot/Icm type IV secretion system (Dot/Icm T4SS) that translocates effector 231	  
proteins and represents a major virulence factor (see below) [53]. 232	  
Genomics of Legionella 233	  
The 3 first complete genomes of L. pneumophila were published in 2004 and a fourth 234	  
sequence from the same species was reported in 2007 [54-56]. Many important factors 235	  
involved in internalization and intracellular proliferation have been identified during the 236	  
pre-genomic era such as Dot/Icm Type IV secretion system, the Type II secretion 237	  
system Lsp and the Mip (macrophage infectivity potentiator) [57, 58] 238	  
The availability of complete L. pneumophila genomes is an open window to better 239	  
understand the L. pneumophila biology. For example, sequence analysis allowed the 240	  
identification of a putative type I secretion system (Lss) encoded by the lssXYZABD 241	  
locus [59]. L. pneumophila genome was also screened to identify patatin-like proteins 242	  
(PLPs) and 11 PLPs were identified designated PatA to PatK. These PLPs form a new 243	  
family of phospholipases. Four of these PLPs (PatA/VipD, PatC/VpdA, PatG/VpdB and 244	  
PatF/VpdC) have been identified and characterized previously [60, 61].  245	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Trancriptional analyses of Legionella 246	  
The first transcriptional study of L. pneumophila using microarrays was performed 247	  
during infection of its natural host, i.e. Acanthamoeba castellanii [62].  Virulence traits 248	  
such as Dot/Icm substrates, factors associated to invasion, virulence and motility as well 249	  
as more than 90 proteins without characterized function, were overexpressed during the 250	  
transmissive phase (>10h post-infection, p.i.) compared to the proliferative phase (<10h 251	  
p.i.). Another transcriptional analysis was performed on L. pneumophila biofilms cells by 252	  
comparing transcriptional profile of sessile cells with two distinct populations of 253	  
planktonic cells [63]. The results showed that sessile cells have a similar gene 254	  
expression profile to proliferative phase L. pneumophila. Recently, to detect putative 255	  
virulence factors involved in resistance to macrophages, the transcriptional response of 256	  
L. pneumophila once internalized by human macrophages, was analysed at 0, 6 and 257	  
18h p.i. and was compared to exponential and post-exponential axenic growth. 258	  
Interestingly, 8 of the 10 most highly induced genes were of unknown function. These 259	  
genes could represent virulence traits. Three new translocated effectors were identified 260	  
by scanning the genome in order to detect regions enriched in genes without assigned 261	  
function and showing a similar expression patterns to their neighbouring effector genes 262	  
[64].  263	  
In addition many putative sRNA molecules were identified by both bioinformatic 264	  
analyses and deep RNA-sequencing on L. pneumophila grown in broth and inside A. 265	  
castellanii [65-68]. Thus, deep RNA-sequencing gave new insights on the global 266	  
transcriptional regulation and response to particular conditions and also helped 267	  
identifying small non-coding RNA involved in the post-transcriptional regulation.  268	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Proteomics investigations 269	  
The first proteomic study performed on L. pneumophila was reported in 2005. This work 270	  
on total cell extracts provided a reference map for further investigations [69]. A 271	  
proteomic approach was also used to identify the T2SS secretome [70, 71], as well as 272	  
the whole secretome [72] and the membranome and surfaceome [73]. Proteomic 273	  
analysis was also performed at both exponential phase and post-exponential phase 274	  
(virulent) of L. pneumophila, to confirm differences observed at the transcription level 275	  
and to identify proteins possibly associated to virulence [74]. This led to the 276	  
identification of 68 proteins among which 64 were overproduced at the post-exponential 277	  
phase. Of these, nine proteins of unknown function were found, among which 6 were 278	  
demonstrated specific for L. pneumophila by southern blot analysis. Two of them were 279	  
associated to haemolysis by conducting contact dependent hemolysis assay using 280	  
SRBC (sheep red blood cells) and two were translocated into macrophages by the 281	  
Dot/Icm T4SS demonstrating the usefulness of proteomics to decipher protein functions. 282	  
Legionella Dot/Icm T4SS  283	  
The T4SS Dot/Icm was identified by various selections and screens for L. pneumophila 284	  
mutants defective for intracellular growth and/or defective for macrophage killing. These 285	  
mutants were called dot for defect in organelle trafficking, in Isberg lab, and icm for 286	  
deficient in intracellular multiplication in Shuman lab [75-80]. Up to now, 26 dot/icm 287	  
genes have been identified and are essential for intracellular growth, in particular to 288	  
prevent phagosome-lysosome fusion.  289	  
More than 300 L. pneumophila effectors have been identified using an arsenal of 290	  
methods such as bioinformatic screens for genes encoding eukaryotic-like domain, 291	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genetic screens for particular phenotypes, yeast screens and translocation screens. 292	  
Sequencing and analysis of the Legionella genome identified a wide variety of proteins 293	  
exhibiting eukaryotic-like domains such as ankyrin repeat, Sel-1, SET, Sec7 motifs, U-294	  
box and F-box domains. Using these bioinformatic approaches, a L. pneumophila 295	  
protein, called RalF, containing a Sec7 homology domain was identified [81]. Sec7 296	  
homology domains are found in a family of eukaryotic ARF-GEF, which stimulates 297	  
exchange of GDP for GTP. Arf1 is a small GTPase involved in the regulation of the 298	  
vesicle traffic between the ER and the Golgi. It was reported that RalF is required for the 299	  
localization of Arf1 on phagosomes containing L. pneumophila. Moreover RalF is 300	  
translocated through the phagosomal membrane by the T4SS Dot/Icm. RalF is the first 301	  
translocated substrate of the T4SS with an identified function.  302	  
One interesting genetic screen relied on the identification of mutant strains, obtained by 303	  
transposon mutagenesis, exhibiting a similar phenotype than that of the dotL mutant, 304	  
i.e. lethality [82].  This lethality is likely due to the assembly of a poison Dot/Icm 305	  
complex, caused by the dysregulation of the molecular flow through the translocator. 306	  
This study allowed the identification of LidA (lowered viability in the presence of dot). 307	  
LidA function was then extensively studied [43, 83-86]. 308	  
The yeast was also exploited to identify and characterized L. pneumophila effectors. A 309	  
yeast lethality screen was performed to identifiy L. pneumophila proteins which interfere 310	  
with yeast growth. This screen led to the identification of YlfA for yeast lethal factor. YlfA 311	  
was also shown to be translocated by the Dot/Icm apparatus and is associated with 312	  
vesicles of the early secretory pathway including ER [87]. The yeast can be also used to 313	  
identify proteins which cause a membrane trafficking (vacuole protein sorting, VPS) 314	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defect in yeast. Using this screen, 3 proteins which inhibit vacuolar traffic were identified 315	  
called VipA (VPS inhibitory protein), VipD and VipF [60]. These 3 proteins are also 316	  
translocated into host macrophages through the Dot/Icm T4SS. VipD possesses a 317	  
patatin domain and is thus also called PatA.  318	  
All these methods considerably improved our knowledge on L. pneumophila intracellular 319	  
life cycle and subversion of host cell processes to its own advantage.  Moreover, yeasts 320	  
represent a useful tool to define the function of putative effectors.  321	  
 322	  
Functional genomics of Chlamydia  323	  
Generalities 324	  
Chlamydia trachomatis and C. pneumoniae are important human pathogens causing 325	  
ocular infection and respiratory diseases such as pneumonia, respectively. Until now, 326	  
we are still unable to genetically manipulate these organisms by targeted mutagenesis 327	  
or transposon mutagenesis, prompting the development of other approaches. One 328	  
major reason for the absence of genetic system to manipulate the genome of 329	  
Chlamydia, resides in the obligate intracellular life cycle of these bacteria. The 330	  
chlamydial development cycle is indeed characterized by two distinct developmental 331	  
stages, which are morphologically and functionally different. Elementary bodies (EBs) 332	  
are the infectious form that may survive extracellularly whereas reticulate bodies (RBs)  333	  
are non-infectious and proliferate inside the host cell. Basically, EBs are internalized 334	  
and differentiate into RBs which replicate by binary fission. RBs then redifferentiate into 335	  
EBs which are released after cell lysis. Finally, EBs initiate a new infection cycle. 336	  
Chlamydia genome and genetic approaches 337	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The complete genome sequence of C. trachomatis and C. pneumonaie were published 338	  
in 1998 and 1999, respectively [88, 89]. 339	  
One interesting approach to tackle the intractability of Chlamydia is the use of a 340	  
combinatorial approach coupling a chemical mutagenesis with whole genome 341	  
sequencing and a system of DNA exchange within infected cells [90]. Practically, 342	  
Chlamydia infected Vero cells were treated with the alkylating agent 343	  
ethylmethylsulfonate (EMS). Mutated Chlamydia were then used to reinfect a monolayer 344	  
of Vero cells, overlaid with agar to observe plaque formation. Mutants were classified 345	  
according to their plaque morphotypes and the whole genome of mutants sequenced to 346	  
identify mutated genes sharing the same phenotype. Finally, co-infection between the 347	  
wild type and mutant strains were performed to obtain recombinants where particular 348	  
mutated genes could be linked to a phenotype. This method led to the identification of 4 349	  
mutants which form large granular plaques (Gnr). Three were mutated in the glgB gene 350	  
encoding a glycogen-branching enzyme. Microscopic analysis of HeLa cells infected 351	  
with Gnr mutants showed an accumulation of large precipitates in the lumen of 352	  
inclusions, likely glycogen. Recombinant strains were obtained to address the link 353	  
between genotype and phenotype and showed that all strains with a mutated glgB 354	  
(even single mutation) were accumulating glycogen inside inclusion. Altogether, a loss-355	  
of-function of glgB is leading to the accumulation of glycogen.  Similarly, in the Gnr4 356	  
mutant, a mutation was identified in the gspE gene which is homologous to ATPases of 357	  
the Type II secretion system. One hypothesis is that gspE mutant accumulates 358	  
glycogen because a key glycogen hydrolase is not secreted. Interestingly, gspE mutant 359	  
is attenuated during HeLa cells infection compared to wild type and glgB mutant strains. 360	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This suggests that the T2SS is involved in the secretion of other factors essential for 361	  
bacterial survival. This combinatorial approach should be applicable to other genetically 362	  
intractable pathogenic bacteria. 363	  
Trancriptional analyses of Chlamydia 364	  
Transcriptomic and proteomic analyses are important to study the global adaptation of 365	  
Chlamydia to their host. Microarray analyses of the temporal gene expression during 366	  
the developmental cycle have been performed, repectively on C. trachomatis serovar L2 367	  
and D [91, 92] and on C. pneumoniae [93]. Belland and colleagues identified 29 early 368	  
genes expressed as early as 1h p.i. [91]. Analysis of these genes suggests that 369	  
Chlamydia established systems for nutrient acquisition and modify its inclusion by 370	  
expressing particular genes during the early stage of infection. Transcriptomic studies 371	  
allowed the definition of a new class of genes called the “very late” (or “tardy” genes), in 372	  
addition to the “late” genes. Basically, “late” genes encode early proteins required for 373	  
EBs infection and “tardy” correspond to genes which mRNA transcripts are present in 374	  
EBs. A total of 26 and 70 “late” genes were respectively, identified by Belland et al. and 375	  
Nicholson et al. [91, 92]. Among these genes, omcAB and hctAB were previously 376	  
characterized as “late” genes. HctAB encodes HctA and HctB, two chlamydial histone-377	  
like proteins, which mediate chromosomal condensation during the differentiation of 378	  
RBs to EBs. OmcAB encodes for OmcA and OmcB are two cysteine-rich outer 379	  
membrane proteins interacting with OmpA, the major outer membrane protein, to form a 380	  
highly disulfide crosslinked complex. This complex is considered essential for the 381	  
resistance of EBs to osmotic stress when outside host cells, since Chlamydia do not 382	  
have a classical peptidoglycan layer. 383	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Recently, RNAseq was performed on the C. trachomatis L2b and C. pneumoniae CWL-384	  
029 on purified elementary bodies and reticulate bodies [94, 95]. For C. trachomatis, 385	  
363 transcription start sites have been mapped and 43 non-coding RNA identified. As 386	  
many as 83 genes showed differential expression level between RBs and EBs [95]. For 387	  
C. pneumoniae, 565 transcriptional start sites of annotated genes and novel transcripts 388	  
were mapped. Semi-quantitatvive analysis showed significant differences in genes 389	  
expression between EBs and RBs for 288 genes. Moreover, 75 non-coding RNA were 390	  
identified [94]. By intergenic tiling microarray on RNA of C. trachomatis D at 40h p.i., 34 391	  
non-coding RNAs were identified, 16 being confirmed by northern blot [96]. One of the 392	  
non-coding RNA regulated ftsI expression by inducing degradation of ftsI mRNA. This is 393	  
especially interesting since in other bacterial lineages, FtsI is involved in peptidoglycan 394	  
synthesis. The true role of FtsI in Chlamydia remains to be determined [97]. Given the 395	  
susceptibility of Chlamydia to penicillin derivatives, the FtsI and others genes of the fts 396	  
operon are likely important in chlamydial multiplication and/or in the biosynthesis of the 397	  
chlamydial peptidoglycan-like layer. 398	  
Proteomics investigations 399	  
Different proteomic studies using 2D gel and mass spectrometry were performed during 400	  
the past 10 years in order to better understand events such as differentiation of EBs to 401	  
RBs. Several studies were performed on purified EBs or on both purified EBs and RBs, 402	  
in order to determine the proteome and study its temporal variation [98-100]. These 403	  
studies confirmed that ORFing of C. trachomatis and C. pneumoniae genomes was 404	  
correct for these hypothetical proteins. It was also showed that the entire set of 405	  
glycolytic enzymes were present in the so-called metabolically inert form (EBs) 406	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suggesting that there are metabolic flux also in EBs. These results were recently 407	  
confirmed by a quantitative study showing that proteins of the central metabolism and 408	  
glucose catabolism were more abundant in EBs, whereas in RBs, proteins involved in 409	  
ATP generation, proteins synthesis, and nutrient transport were predominant [101]. 410	  
Proteomic approaches were also used to identify translocated chlamydial proteins into 411	  
host cell cytoplasm [102, 103]. The first study allowed the identification of CPAF 412	  
(chlamydial protease or proteasome-like activity factor), a factor previously 413	  
characterized by Zhong and colleagues [104]. A second study allowed the identification 414	  
of CT621, which localized to the host cell cytoplasm and nucleus and whose 415	  
translocation is dependent of the T3SS [103]. 416	  
An ORFeome was recently constructed for C. pneumoniae [105]. The ORFeome is an 417	  
essential tool for functional genomics of such intractable bacteria allowing functional 418	  
screens in yeast such as two-hybrid, lethality screen, membrane traffic defect, adhesion 419	  
assays, as well as screen to identify T3SS translocated proteins, for instance by 420	  
heterologous expression in Shigella using reporter gene fusions. 421	  
Advances in Chlamydia transformation 422	  
In one of the pioneering works in this field, Binet and colleagues [106] constructed pUC 423	  
plasmid derivatives carrying different lengths of rRNA regions containing 4 nucleotide 424	  
substitutions. Three substitutions located in the 16Sr RNA gene conferred resistance to 425	  
kasugamycin and spectinomycin, and caused a loss of one HpaI restriction site. C. 426	  
psittaci 6BC was then electroporated with various concentrations of circular or linearized 427	  
plasmids. Allelic replacements of the endogenous rRNA operon were selected by 428	  
incubation of the infected cells with the two antibiotics. Allelic replacements were 429	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observed at frequencies greater than 10-6. This showed that genetic manipulations are 430	  
feasible in Chlamydia. Recently, C. trachomatis transformation was reported using 431	  
penicillin selection and calcium chloride treatment of EBs to render them competent 432	  
[107]. A GFP plasmid was constructed based on the plasmid of the Swedish new 433	  
variant strain (a strain with a deletion of a 400bp region in the canonical 7’500kb 434	  
plasmid of C. trachomatis). This plasmid was used to obtain penicillin resistant C. 435	  
trachomatis strains expressing gfp. These recent advances in C. trachomatis 436	  
transformation and mutagenesis by allelic recombination in C. psittaci open the window 437	  
to future development of genetic tools in order to perform targeted and random 438	  
mutagenesis, which could considerably improve our knowledge on the biology of these 439	  




During the last two decades, complete genomes were obtained for many bacteria. All 444	  
these data are however not sufficient to understand the bacterial biology. This led to the 445	  
development of functional genomics whose main feature is its genome-wide approach 446	  
(Figure 2). One challenge of the functional genomics on intracellular pathogen is to 447	  
discriminate bacterial material from host cell material. The early times post-infection are 448	  
also critical since there is not yet bacterial proliferation and we have to deal with very 449	  
small amount of bacteria. Functional genomics approaches are useful to better 450	  
understand host-pathogen interaction which is tightly regulated by the two interacting 451	  
partners and leads to accumulating data at the DNA, RNA and protein level. These data 452	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are quite difficult to interpret and need to conciliate all 3 levels. Each approach presents 453	  
advantages and limitations which are summarized in the Table 1. One major 454	  
disadvantage of microarray analysis is that results may be different than results 455	  
obtained at proteomic level due to post-transcriptional modifications. It is therefore 456	  
interesting to perform both analyses in parallel on a same sample. The main 457	  
disadvantage of proteomic studies, using 2D gel and mass spectrometry, is that they 458	  
require supplementary steps to separate/distinguish host cell proteins from bacterial 459	  
proteins. RNAseq compared to microarrays, has several advantages, and especially in 460	  
term of cost and quality of data, but this new technology has not yet been much applied 461	  
to intracellular pathogenic bacteria. RNAseq also require differentiating bacterial RNA 462	  
and host cell RNA. This is possible by mapping reads to reference bacterial genome 463	  
sequence or, before the RNAseq, by a physical separation of bacteria from host cells or 464	  
by sequential purification steps to isolate bacterial RNA. 465	  
Genome-wide studies give a global view of the bacterial response to a particular 466	  
environment. They may be combined with specific functional screens in order to 467	  
determine the role of a particular protein.  468	  
Extracellular pathogenic bacteria secrete toxins/enzymes which are considered as 469	  
virulence factors. For intracellular bacteria, toxins/enzymes counterparts are effector 470	  
proteins. These proteins are translocated by a secretion system and are involved in the 471	  
host cell hijacking. Intracellular pathogenic bacteria possess a battery of non-canonical 472	  
effectors with redundant functions, rendering their identification extremely difficult. In 473	  
this context, functional genomics approaches are very useful tools. 474	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In the future, functional genomics will increasingly use RNAseq and will likely also 475	  
investigate bacterial metabolism using metabolomics. The major interest of RNAseq is 476	  
the identification of non-coding RNAs which are new actors in genes regulation. Non-477	  
coding RNA role is still likely underestimated. By giving a snapshot of the metabolites 478	  
present at a define time, metabolomics will provide important insights into bacterial 479	  
physiology. The next challenge in the functional genomics field is to integrate data from 480	  
transcriptomic, proteomic and metabolomic studies in order to obtain a global picture of 481	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Figure 1. Graph showing the increasing number of hits when we made a NCBI research 816	  
with particular key words. This reflects the expansion of the functional genomics during 817	  







Figure 2. Timeline for Chlamydia spp., Brucella spp. and Legionella spp. during  823	  













Table1.   Advantages and limitations of various genomewide 835	  
approaches to define genes function of Legionella, Chlamydia and 836	  
Brucella spp.   837	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